-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-selection-harms-systematic-reviews.pdf
February 01, 2018 - Prioritization and Selection of Harms for Inclusion in Systematic Reviews
Prioritization and Selection of Harms
for Inclusion in Systematic Reviews
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Presenter
Presentation Notes
P…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - 45
Abstract
Characterization of exposure is a central issue in the analysis of observational data; however, no “one
size fits all” solution exists for exposure measurement. In this chapter, we discuss potential exposure
measurement approaches for observational comparative effectiveness research (CER). First, it is …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_research-protocol.pdf
June 12, 2014 - Existing reviews that we are considering including (in total or in part) as evidence will be
assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - - eg. page 35, line 28-29 'surprisingly' ;
page 36 line 19-20 'this is especially important when
considering
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
December 08, 2014 - In considering the applicability of the findings to patients, we
will consult large studies to ascertain
-
effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
May 26, 2016 - need to keep the scope of this
project focused on disparities within the SMI population,
rather than considering
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - It is too simplistic and not
considering the research question, clinical and methodological diversity … substantial heterogeneity
needs explanation, but lack of explanation should not diminish its
impact when considering
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_consumer.pdf
July 01, 2016 - Treatments for Fecal Incontinence: A Review of the Research for Adults
Treatments for Fecal
Incontinence
A Review of the Research for Adults
e
Archived: This report is greater than 3 years
old. Findings may be used for research
purposes, but should not be considered
current
…
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/are-there-data-supporting-the-discontinuance-of-warfarin-after-catheter-ablation-for-atrial-fibrillation-what-is-the-prevalence-of-symptomatic-and-asymptomatic-atrial-fibrillation-after-catheter-ablation
February 27, 2012 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description
Topic Suggestion Description
Date submitted: February 27, 2012
Download Topic Suggestion Disposition [PDF · 54.6 KB]
Briefly describe a specific question, or set of related questions, about a healt…
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
August 01, 2013 - The horizon scanning team operationalizes this definition by considering interventions in
the context … We also provide below
reasons why these questions are asked and answered when considering whether a … While considering the presentations, team members and any guest attendees with subject
matter expertise … ask experts for their opinions about patient acceptance
or adoption of an intervention, we are also considering … These parameters are
intended to serve as anchoring points for considering the overall potential impact
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
November 12, 2020 - G-1. Additions to ROB Template
Table G-2. Additions to risk of bias template
Rater Author, Year Selection Bias Domain: Randomization Adequate? Selection Bias Domain: Allocation Concealment Adequate? Selection Bias Domain: Groups Similar at Baseline? Selection Bias Domain: ITT Analysis? Performance Bias Domain: Care P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
November 12, 2020 - G-1. Additions to ROB Template
Table G-2. Additions to risk of bias template
Rater Author, Year Selection Bias Domain: Randomization Adequate? Selection Bias Domain: Allocation Concealment Adequate? Selection Bias Domain: Groups Similar at Baseline? Selection Bias Domain: ITT Analysis? Performance Bias Domain: Care P…
-
effectivehealthcare.ahrq.gov/products/acute-pain-ems/protocol
October 30, 2018 - Overall conclusions and SOE will be assessed considering how the effect estimates and the confidence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
February 01, 2012 - For each FRN topic, stakeholders were asked to provide a brief
rationale (maximum 250 words) considering … When considering clinical outcomes, there is a potential for a large loss in
followup. … Framework for Considering Study
Designs for Future Research Needs (FRN). … Efficiency (i.e., considering the timing of the need for new evidence, it is likely
that a result could … Costs associated with the likely study design are reasonable considering limited
program resources
-
effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
April 01, 2016 - transportation, communications industries, health
care) is underrepresented in included studies when
considering
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
March 21, 2016 - In
considering the interventions used most have been successful with
certain SNF residents. … the ultimate goal of bringing
the person back in line with what WE feel is best for him either not
considering
-
effectivehealthcare.ahrq.gov/products/hypothyroidism-hyperthyroidism-screening-treatment/research-protocol
March 10, 2010 - This uncertainty impacts the decision-making for clinicians who are considering treatments for subclinical
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-approaches_research.pdf
June 01, 2011 - This paper
provides a framework for understanding the possibilities, considering influential factors … approach involves a
consideration of the results of randomized trials (i.e., their conclusiveness) when considering … Our goal in this paper
has been to provide a framework for understanding the possibilities, considering
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-2.pdf
December 01, 2021 - Rapid Evidence Product: Masks for Prevention of COVID-19 in Community and Healthcare Settings Version 2
Rapid Evidence Product
Version 2.0 (June 24, 2020)
Masks for Prevention of COVID-19 in
Community and Healthcare Settings
Background and Purpose
Currently, no proven treatments are available for coronavirus d…
-
effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-Spanish-DA.pdf
September 01, 2016 - ¿Es la prueba para detectar el cáncer pulmonar apropiada para mí?
¿Es la prueba para detectar el
cáncer pulmonar apropiada para
mí?
Herramienta que le ayudará a decidir si
está considerando hacerse la prueba para
detectar el cáncer pulmonar con tomografía
computarizada de dosis baja
Si ha fumado durante mu…